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LEDGFp75 is a cellular protein which binds human immunodeficiency virus type 1 (HIV-1) integrase
with high specificity and affinity but whose function in infection has not been defined. We infected
LEDGFp75-deficient primary macrophages with wild-type HIV in order to assess potential infection
phenotypes which would provide clues to LEDGFp75 function. Silencing of LEDGFp75 by 70 to 80%
resulted in an average of 53% reduced infection of macrophages by HIV. Analysis of infection interme-
diates showed that integration, but not two-long-terminal-repeat (2LTR) circles or late cDNAs, was
reduced up to 74% in LEDGFp75-deficient macrophages. Therefore, LEDGFp75 has a modest involvement
in HIV-1 integration in macrophages.
Human immunodeficiency virus type 1 (HIV-1) cDNA is
integrated into cellular DNA through a biochemically de-
scribed process dependent on the catalytic activity of viral
integrase protein. The preintegration complex (PIC) consists
of a multiprotein complex containing viral and cellular pro-
teins. Several cellular proteins have been found to interact
with integrase in vitro and stimulate the in vitro integration
reaction. These proteins include BAF, HMGA, INI1, and
LEDGFp75 (lens epithelium-derived growth factor p75) (3,
6–8).
LEDGF exists in two major splice forms, which result in
52- and 75-kDa proteins (13). While the 75-kDa form inter-
acts with integrase, the 52-kDa form lacks the integrase-
binding region (11). LEDGFp75 is a nuclear protein which
functions as a transcription factor for LEDGF-responsive
genes (12). Initial work using RNA interference (RNAi) to
knock down LEDGFp75 in cell lines caused exogenously
expressed integrase to be defective in nuclear accumulation
and chromosomal tethering (1, 9, 11, 14). Curiously, dis-
agreement exists about whether an infection defect can be
attributed to LEDGFp75-deficient cells (5, 9). This may be
due to the fact that these studies utilized cell lines as exper-
imental models of HIV infection rather than natural targets
or integrase mutants which potentially have pleiotropic de-
fects (10).
In the work described here, we investigated HIV infection
of human primary macrophages by replication-competent
HIV-1 following RNAi of LEDGFp75. We found modest
but reproducible inhibition of macrophage infection in ap-
proximate proportion to the degree of LEDGFp75 knock-
down. We localized this defect to occur after nuclear entry
at the step of integration. Nuclear import is unaffected. Our
data support a hypothesis in which LEDGFp75 increases in
vivo integration efficiency by favoring the interaction of the
PIC with genomic DNA.
Viral cDNA coimmunoprecipitates with LEDGFp75 in mac-
rophages. Previous work has shown that LEDGFp75 binds
exogenously expressed integrase protein (3). Llano et al. (9)
showed not just that LEDGFp75 is a binding partner of inte-
grase but also that association occurs in the context of func-
tional HIV vector PICs in 293T cells. We therefore set out to
determine whether LEDGFp75 bound viral cDNA-containing
complexes in primary macrophages infected with wild-type
HIV by looking for viral cDNA in anti-LEDGFp75 immuno-
precipitates.
To accomplish this, we used macrophages differentiated
from elutriated monocytes obtained from healthy donors.
Macrophages were infected with vesicular stomatitis virus G
(VSV-G)-pseudotyped HIVLAI (produced in 293T cells), and
cell extracts were collected in radioimmunoprecipitation assay
buffer 12 h postinfection. LEDGF was immunoprecipitated
using anti-LEDGF antibody (Becton Dickinson), and the final
pellet was subjected to PCR using primers in gag and the LTR
(W primer, 5-GGGAGCTCTCTGGCTAACT-3; BB primer,
5-GGATTAACTGCGAATCGTTC-3) to detect the pres-
ence of viral cDNA. Three controls were used: an uninfected
macrophage sample, an infected sample immunoprecipitated
with anti-LIG1 (Abcam), and an uninfected sample spiked
with the infectious molecular clone plasmid used for HIV
preparation.
HIV viral cDNA was detected in the LEDGF precipitate
from the HIV-infected sample, while no signal was observed
in the uninfected sample, the infected sample immunopre-
cipitated with anti-LIG1 antibody, or the plasmid spike con-
trol (Fig. 1). No signal with the plasmid spike indicates that
a positive signal is not due to DNA carryover and that
LEDGFp75 does not bind directly to viral cDNA under
these conditions. These data show that LEDGFp75 associ-
ates with the PIC of wild-type HIV in human primary mac-
rophages.
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Impaired infection of macrophages deficient in LEDGFp75.
Although LEDGFp75 binds to integrase, no significant infec-
tion defect has been observed in LEDGFp75-deficient cell
lines by us (data not shown) and others (9). However, this
question has not been investigated in primary cells with natural
HIV infection. We thus chose human macrophages as a natu-
ral HIV target for investigation of the effect of LEDGFp75
deficiency on infection.
LEDGFp75 expression was silenced in macrophages by trans-
fection of LEDGFp75-specific small interfering RNA (siRNA)
(5-AGACAGCATGAGGAAGCGATT-3; Ambion) once per
day for 2 days as previously described (15). A nonspecific siRNA
sequence (NS; 5-TTCTCCGAACGTGTCACGTTT-3) was trans-
fected into cells as a control. The efficiency of LEDGFp75 knock-
down was measured by quantitative RT-PCR of LEDGFp75
mRNA (primer LEDGF-1460F, 5-CAGGTCACAATGCAA
CAAGC-3; primer LEDGF-1671R, 5-TTCGCTTCCTCAT
GCTGTCT-3) and normalized to LIG3 mRNA (primer LIG3up,
5-GGCTGGGAAGAGCTGGAAGATAAT-3; primer LIG3dn,
5-TGATCTGGGTCTTCGTGTTGTAGC-3) and Western blot-
ting. RT-PCR revealed a 70 to 80% reduction of LEDGFp75
mRNA for up to 3 days posttransfection, which roughly cor-
responds to the reduction in protein levels observed by West-
ern blotting (Fig. 2A).
LEDGFp75 or NS control siRNA-transfected macrophages
were infected with HIVNL4-3/GFP, carrying a green fluores-
cent protein (GFP) marker gene in place of nef, on the day
following the second siRNA transfection. Since NL4-3 is T
tropic, these infections are single round. After 4 days, mac-
rophages were harvested and subjected to flow cytometry in
order to quantify the proportion of infected cells according
to GFP fluorescence (Fig. 2B). We found that macrophages
undergoing LEDGFp75 silencing consistently exhibited de-
creased susceptibility to productive HIV infection com-
pared to control cells, averaging 53% fewer HIV-infected,
LEDGFp75-deficient macrophages (Fig. 2C; P  0.04, n 
5). We achieved an average infection of 9.0% of NS control
macrophages compared to 4.4% of LEDGFp75-deficient
macrophages. Accordingly, virus output from LEDGFp75-
deficient cultures 6 days postinfection was reduced approx-
imately 67% (data not shown). LEDGFp75 silencing did not
affect viral gene expression, since GFP mean fluorescence
intensity (MFI) was unchanged in infected cells, indicating
that LEDGFp75 acted early in infection (Fig. 2D; P  0.10,
n  3).
Decreased infection was not a consequence of cell death due
to LEDGFp75 knockdown. Lactate dehydrogenase (LDH) is a
cytoplasmic enzyme released from the cell early upon damage
to the cell membrane and death. To assess cell toxicity due to
LEDGFp75 RNAi, we measured LDH release from siRNA-
transfected macrophages 4 to 6 days posttransfection (Fig. 2D).
We found no significant toxicity associated with LEDGFp75
knockdown, suggesting that decreased HIV infection of macro-
phages cannot be explained by toxic effects of LEDGFp75 defi-
ciency or siRNA transfection.
It has been reported by Cherepanov et al. (2) that a motif
present in the integration binding domain of LEDGFp75 is
also present in other proteins. One of these, HRP-2, encoded
by the HDGF2 gene, was shown to bind HIV integrase and
stimulate integration in vitro. We considered that the residual
infection observed following LEDGFp75 knockdown could be
due to HRP-2 activity. Our preliminary results show that in-
fection of macrophages in which HDGF2 has been silenced
does not result in decreased infection. Neither is there a greater
effect when HDGF2 is silenced together with LEDGFp75 (data
not shown).
Overall, these data show that LEDGFp75 plays an impor-
tant positive role in HIV infection of macrophages.
Impaired macrophage infection is the result of reduced
HIV integration. The point at which LEDGFp75 activity is
important for HIV infection of macrophages was investi-
gated by measurement of the accumulation of viral cDNA
intermediates and integration following LEDGFp75 knock-
down and HIV infection. LEDGFp75 was silenced by RNAi,
and the day following transfection, macrophages were in-
fected with VSV-G-pseudotyped HIVLAI. These infections
were single round, as LAI cannot infect macrophages with-
out VSV-G pseudotyping. DNA was prepared from macro-
phages 1 to 5 days postinfection using DNAzol, and viral
cDNA intermediates (2LTR and late cDNAs) were quanti-
fied by real-time PCR, normalizing to CCR5 gene copies, as
previously described (15).
Integrated provirus was quantified using real-time, single-
step Alu-PCR. In this approach, PCR amplicons were directly
quantified using primers in gag and genomic Alu repeats (gag,
W primer [above]; AluR, 5-TGCTGGGATTACAGGCGTG
AG-3) and a TaqMan probe complementary to viral sequence
(5-AGCCTCAATAAAGCTTGCCTTGAGTGC-3). Values
are relative, as was the DNA standard, thus rendering inequi-
ties in amplicon amplification efficiencies equivalent between
standards and unknowns. Integrated provirus could be de-
tected after 25 to 35 cycles, was reproducible among replicates,
and generated standard curves with R2 values near 1.0 and
slopes near 3.3 without resorting to nested PCR (Fig. 3A). In
Fig. 3B, we show the results of three experiments where com-
pletion of reverse transcription (late cDNAs), nuclear import
FIG. 1. Coimmunoprecipitation of viral cDNA. HIV-infected mac-
rophage extracts were immunoprecipitated with anti-LEDGF or anti-
LIG1 (control) antibody, followed by PCR analysis of pellets for the
presence of viral cDNA. “PCR control” indicates PCR of an HIV
clone plasmid. The last lane was uninfected macrophage extracts
spiked with 90 ng HIV clone plasmid before LEDGF immunoprecipi-
tation. Viral cDNA could be detected in infected extracts immuno-
precipitated with anti-LEDGF antibody but not anti-LIG1 antibody,
indicating LEDGF association with a viral cDNA complex in wild-
type-infected primary macrophages. The signal was not due to carry-
over plasmid, since an irrelevant antibody produced no signal.
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(2LTR circles), and integration (Alu-PCR) were measured and
compared to results for NS control cells.
Accumulation of late cDNAs was similar between LEDGFp75-
deficient and NS controls cells (Fig. 3B and C), indicating that
LEDGFp75 does not influence reverse transcription in mac-
rophages. Kinetic analysis of 2LTR circle formation, a mea-
surement of nuclear import, showed an increased over the
period analyzed, in one case reaching a plateau by day 5 (ex-
FIG. 2. Infection of LEDGFp75-deficient macrophages. A. Analysis of LEDGFp75 RNAi by RT-PCR and Western blotting. LEDGFp75 mRNA
was quantified by real time RT-PCR, normalized to LIG3 mRNA, and compared to NS control siRNA-transfected cells. LEDGFp75 mRNA levels were
decreased 70 to 80%. The second panel shows a representative Western blot for LEDGF showing LEDGFp75 protein knockdown at 2 to 4 days
posttransfection. B. NS control or LEDGFp75-silenced macrophages were infected with HIVNL4-3/GFP, and the proportion of infected cells was
measured by flow cytometry. A representative flow cytometry histogram shows that macrophages deficient in LEDGFp75 displayed reduced susceptibility
to HIV infection. C. An average of five experiments shows that reduced infection of LEDGFp75-deficient macrophages was consistent and significantly
lower than infection of NS control cells (P  0.0013). D. Infected macrophage cultures were subjected to flow cytometry, and the MFI of GFP cells
was measured. Values for LEDGFp75-deficient cells were normalized to NS control cells. Data indicate that the infection defect observed is due to
LEDGFp75 acting during early events in the viral life cycle. E. Potential cell toxicity due to LEDGFp75 deficiency or RNAi was assessed by measurement
of LDH activity in culture supernatants following siRNA transfection. Only marginal increases in LDH activity were observed in siRNA-transfected
cultures compared to unmanipulated cultures. LDH, LDH control from the assay kit.
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periment 3). No significant decrease in 2LTR circle formation
was observed in macrophages undergoing LEDGFp75 silenc-
ing, compared to NS control macrophages (Fig. 3B and C).
These data indicate that LEDGFp75 does not influence trans-
location of the PIC to the nuclear compartment and that de-
creased infection in LEDGFp75-deficient macrophages is not
due to decreased PIC nuclear import.
In following the progress of integration over a 5-day period,
we found that macrophages deficient in LEDGFp75 consis-
tently exhibited reduced integration by 5 days postinfection
(Fig. 3B). In contrast, NS control cells generally continued to
accumulate integrated provirus up to 5 days postinfection, the
duration of analysis. The defect in integration was significant at
5 days postinfection (P  0.004), with an average reduction
compared to NS control cells of 74% (Fig. 3C). Decreased
infection of LEDGFp75-deficient macrophages (Fig. 2) was
therefore accompanied by a defect in integration, thus sup-
porting a role for LEDGFp75 in this process.
In this study, we investigated the role of LEDGFp75 in HIV
infection of macrophages. We found LEDGFp75 associated
with a complex containing viral cDNA in infected macro-
phages, probably through interaction with integrase. Using
RNAi technology, knockdown of LEDGFp75 resulted in a
modest decrease in HIV infection of macrophages, roughly
corresponding to the degree of LEDGFp75 knockdown. In
preliminary work, HRP-2, another integrase binding protein,
did not compensate for residual LEDGFp75 protein or result
in decreased HIV infection upon its silencing (data not
shown). Remaining macrophages infection may be due to in-
complete LEDGFp75 silencing. Analysis of the part of the
viral life cycle whereby LEDGFp75 functioned localized the
activity to integration. Knockdown of LEDGFp75 had no ef-
fect on production of complete reverse transcripts or 2LTR
circles; however, LEDGFp75-deficient macrophages displayed
impaired, but not the absence of, integration, as measured by
real-time PCR.
In other studies, investigators were unable to find a defect
in HIV infection or the expression of a reporter gene incor-
porated into the virus in cell lines rendered stably deficient
in LEDGFp75 (9). Likewise, we were unable to observe
more than a slight effect on infection of HeLa cells (data not
shown). The greater efficiency of infection and metabolic
activity of cells lines than macrophages may negate the need
for LEDGFp75. Second, it cannot be excluded that another
protein present in various cell lines but not macrophages can
compensate for the loss of LEDGFp75. Emiliani et al. (5) re-
ported that integrase mutants unable to bind LEDGFp75 are
defective for replication in cell lines. Integrase mutants are
often plagued by unrelated pleiotropic defects (10). Neverthe-
less, our data using RNAi support their conclusions and extend
them to primary cell targets of natural HIV infection.
The specificity and strength of the LEDGFp75-integrase
interaction as determined by crystal structure analysis suggest
an important role for LEDGFp75 in HIV biology (4). Initial
work focused on potential nuclear import functions, since the
mechanism of HIV PIC nuclear import is largely unknown.
However, this hypothesis has not stood up to experimental
results as described here, in macrophages, or in the work of
others (9).
LEDGFp75 has been described as ‘tethering’ the PIC to
genomic DNA (1, 5, 11, 14). We report impaired integration
in LEDGFp75-silenced macrophages, a phenotype which is con-
sistent with LEDGFp75 functioning in this manner. LEDGFp75
could also associate with other protein components of the PIC
whereby loss of LEDGFp75 results in altered assembly/disassem-
bly or stability of a complex which functions to enhance alignment
of the PIC on target DNA.
In conclusion, we show that LEDGFp75 is able to bind to
viral cDNA-containing complexes in macrophages. Silencing
of LEDGFp75 expression results in a modest reduction in
macrophage infection as a result of a defect in integration,
while nuclear import and reverse transcription are un-
changed. Overall, these data point to LEDGFp75 playing an
FIG. 3. Analysis of HIV life cycle intermediates. A. Viral integra-
tions per cell were directly quantified using real-time PCR. Sensitivity
was sufficient to detect integration without using nested PCR. The top
panel shows a representative amplification plot of duplicate samples
used for standard curve generation. These samples were derived from
previously infected macrophage extracts which were serially diluted to
establish the shown range. Arrows show the crossing point for each
pair. The two samples not amplified are no-template controls. Curves
for duplicates frequently overlap. The bottom panel shows the result-
ing standard curve. Arrows mark locations of standards. Other points
are unknown samples. B. Late cDNAs, 2LTRs, and integrations were
followed for 5 days following HIV infection of NS control or
LEDGFp75-silenced macrophages. In experiments 2 and 3, an infected
macrophage culture was treated with nevirapine as a negative control.
Reverse transcription and nuclear import were largely normal in
LEDGFp75-deficient cells, while integration was reduced, particularly
at later time points. The 3-day time point for LEDGF in experiment 3
appears to be an outlier and possibly represents a technical error. C.
LEDGFp75 data for each experiment were divided by the values for
their corresponding NS controls to achieve normalized values and then
averaged, to show that only integration was affected in LEDGFp75-
deficient cells, reaching significance by 5 days postinfection (P 
0.0044).
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important role during HIV integration into macrophages
and lay the groundwork for more targeted studies in the
future.
We thank M. Sharkey and J. M. Jacque (University of Massachu-
setts) for helpful discussions.
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